Table 3 Prevalence of gametocytaemia, Magaria, Niger, 2016–2018
From: Prevalence of malaria in an area receiving seasonal malaria chemoprevention in Niger
High season survey 1 October 2016 (N = 588) | Low season survey 1 December 2016 (N = 634) | High season survey 2 September 2017 (N = 818) | Low season survey 2 February 2018 (N = 643) | |||||
|---|---|---|---|---|---|---|---|---|
Prevalence | 95% CI | Prevalence | 95% CI | Prevalence | 95% CI | Prevalence | 95% CI | |
Gender | ||||||||
Male | 14.4 | 10.7–19.0 | 7.4 | 4.9–11.0 | 13.3 | 10.2–17.3 | 6.0 | 3.9–9.2 |
Female | 11.8 | 8.3–17.7 | 8.5 | 5.6–12.7 | 9.7 | 7.2–13.0 | 5.2 | 3.2–8.2 |
Age | ||||||||
3–59 months | 19.3* | 14.6–25.2 | 12.4* | 8.6–17.6 | 16.4* | 12.5–21.3 | 9.9* | 6.5–14.8 |
5–9 years | 18.5 | 12.7–26.1 | 13.1 | 8.6–19.4 | 16.2 | 11.5–22.4 | 6.3 | 3.5–11.1 |
≥ 10 years | 4.9 | 2.8–8.4 | 1.5 | 0.6–3.9 | 5.5 | 3.6–8.4 | 1.6 | 0.6–4.1 |
Type of SMC in the area | ||||||||
DOT | 14.1 | 10.5–18.6 | 7.7 | 5.0–11.6 | 11.5 | 9.3–14.1 | 5.6 | 4.0–7.8 |
Non-Dot | 11.9 | 8.4–16.6 | 8.1 | 5.4–11.9 | – | – | – | – |